Report cover image

Conjunctivitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Disease Type; By Route of Administration (Topical, Oral); By Formulation Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

Publisher Polaris Market Research & Consulting LLP
Published Feb 24, 2024
Length 117 Pages
SKU # PLRS18618362

Description

Conjunctivitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Disease Type; By Route of Administration (Topical, Oral); By Formulation Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032



The global conjunctivitis treatment market size is expected to reach USD 5.83 billion by 2032, according to a new study by Polaris Market Research. The report “Conjunctivitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Disease Type; By Route of Administration (Topical, Oral); By Formulation Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

An increasing incidence of conjunctivitis is the primary driver for the growth of the conjunctivitis treatment market. Moreover, the strong focus of the industry players towards the research & development for the introduction of more effective treatment and increasing healthcare spending is expected to contribute to the market growth throughout the forecast period. Furthermore, sharing of clothes, eye contact with contaminated objects, hand-to-eye contact, and mutual usage of personal & cosmetic products increases the risk of conjunctivitis, which ultimately propels the demand for its treatment.

The introduction of new technologies in the field of ophthalmology treatment, the increasing number of patient visits for regular eye checkups, and rapid growth in the number of people seeking medical treatment for conjunctivitis are anticipated to fuel the expansion of the conjunctivitis treatment market in the coming years. Moreover, a growing number of people with low vitamin D levels are more likely to be infected with severe conjunctivitis. For instance, according to a research study of tears from around 335 conjunctivitis patients at the Narayana Nethralaya’s GROW (Genes Repair & Regeneration in Ophthalmic Workstation) Lab, nearly 60% of the 220 patients also had low levels of Vitamin D. Thus, an increasing number of patients with low vitamin D levels are expected to fuel the overall market growth.

Moreover, the strong preference of consumers for topical medications coupled with an increasing number of product launches that are applied topically will drive the market expansion. Furthermore, many ongoing clinical trials for the introduction of new products are expected to provide significant growth opportunities for the market growth.

Conjunctivitis Treatment Market Report Highlights

The anti-allergic segment dominated the market, owing to the growing incidence rate of ocular allergies.

The allergic conjunctivitis segment held the largest market share, owing to an increasing number of patients suffering from the disease.

The topical segment accounted for the largest share of the market, owing to the ability of this type of treatment to deliver the drug at the appropriate sites of infection.

The tablets & capsules segment captured the largest market share, owing to the rising prescription volume of tablets for conjunctivitis.

North America accounted for the largest market share, owing to the high prevalence of conjunctivitis and strong focus of companies towards new product launches.

The market players include Abbvie Inc, Novartis, Bausch Health Companies Inc., Harrow, NicOx SA, Alembic Pharmaceuticals, AFT Pharmaceuticals, etc.

Polaris Market Research has segmented the conjunctivitis treatment market report based on drug class, disease type, route of administration, formulation type, distribution channel, and region:

Conjunctivitis Treatment, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

Antibiotics

Antiviral

Anti-allergic

Artificial Tears

Others

Conjunctivitis Treatment, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

Bacterial Conjunctivitis

Viral Conjunctivitis

Allergic Conjunctivitis

Conjunctivitis Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Topical

Oral

Conjunctivitis Treatment, Formulation Type Outlook (Revenue - USD Billion, 2019 - 2032)

Tablets & Capsules

Drops

Others

Conjunctivitis Treatment, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies & Drug Stores

Conjunctivitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

117 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Conjunctivitis Treatment Market Insights
4.1. Conjunctivitis Treatment – Industry Snapshot
4.2. Conjunctivitis Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Growing prevalence of conjunctivitis
4.2.1.2. Rising research & development (R&D) activities
4.2.2. Restraints and Challenges
4.2.2.1. Side effects related to the conjunctivitis treatment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Conjunctivitis Treatment Industry Trends
4.6. COVID-19 Impact Analysis
5. Global Conjunctivitis Treatment Market, by Drug Class
5.1. Key Findings
5.2. Introduction
5.2.1. Global Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
5.3. Antibiotics
5.3.1. Global Conjunctivitis Treatment Market, by Antibiotics, by Region, 2019-2032 (USD Billion)
5.4. Antiviral
5.4.1. Global Conjunctivitis Treatment Market, by Antiviral, by Region, 2019-2032 (USD Billion)
5.5. Anti-allergic
5.5.1. Global Conjunctivitis Treatment Market, by Anti-allergic, by Region, 2019-2032 (USD Billion)
5.6. Artificial Tears
5.6.1. Global Conjunctivitis Treatment Market, by Artificial Tears, by Region, 2019-2032 (USD Billion)
5.7. Others
5.7.1. Global Conjunctivitis Treatment Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Conjunctivitis Treatment Market, by Disease Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
6.3. Bacterial Conjunctivitis
6.3.1. Global Conjunctivitis Treatment Market, by Bacterial Conjunctivitis, by Region, 2019-2032 (USD Billion)
6.4. Viral Conjunctivitis
6.4.1. Global Conjunctivitis Treatment Market, by Viral Conjunctivitis, by Region, 2019-2032 (USD Billion)
6.5. Allergic Conjunctivitis
6.5.1. Global Conjunctivitis Treatment Market, by Allergic Conjunctivitis, by Region, 2019-2032 (USD Billion)
7. Global Conjunctivitis Treatment Market, by Route of Administration
7.1. Key Findings
7.2. Introduction
7.2.1. Global Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
7.3. Topical
7.3.1. Global Conjunctivitis Treatment Market, by Topical, by Region, 2019-2032 (USD Billion)
7.4. Oral
7.4.1. Global Conjunctivitis Treatment Market, by Oral, by Region, 2019-2032 (USD Billion)
8. Global Conjunctivitis Treatment Market, by Formulation Type
8.1. Key Findings
8.2. Introduction
8.2.1. Global Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
8.3. Tablets & Capsules
8.3.1. Global Conjunctivitis Treatment Market, by Tablets & Capsules, by Region, 2019-2032 (USD Billion)
8.4. Drops
8.4.1. Global Conjunctivitis Treatment Market, by Drops, by Region, 2019-2032 (USD Billion)
8.5. Others
8.5.1. Global Conjunctivitis Treatment Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Conjunctivitis Treatment Market, by Distribution Channel
9.1. Key Findings
9.2. Introduction
9.2.1. Global Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
9.3. Hospital Pharmacies
9.3.1. Global Conjunctivitis Treatment Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
9.4. Online Pharmacies
9.4.1. Global Conjunctivitis Treatment Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)
9.5. Retail Pharmacies & Drug Stores
9.5.1. Global Conjunctivitis Treatment Market, by Retail Pharmacies & Drug Stores, by Region, 2019-2032 (USD Billion)
10. Global Conjunctivitis Treatment Market, by Geography
10.1. Key findings
10.2. Introduction
10.2.1. Conjunctivitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
10.3. Conjunctivitis Treatment Market – North America
10.3.1. North America: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.3.2. North America: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.3.3. North America: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.3.4. North America: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.3.5. North America: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.3.6. Conjunctivitis Treatment Market – U.S.
10.3.6.1. U.S.: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.3.6.2. U.S.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.3.6.3. U.S.: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.3.6.4. U.S.: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.3.6.5. U.S.: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.3.7. Conjunctivitis Treatment Market – Canada
10.3.7.1. Canada: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.3.7.2. Canada.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.3.7.3. Canada: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.3.7.4. Canada: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.3.7.5. Canada: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4. Conjunctivitis Treatment Market – Europe
10.4.1. Europe: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.2. Europe.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.3. Europe: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.4. Europe: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.5. Europe: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.6. Conjunctivitis Treatment Market – UK
10.4.6.1. UK: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.6.2. UK.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.6.3. UK: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.6.4. UK: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.6.5. UK: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.7. Conjunctivitis Treatment Market – France
10.4.7.1. France: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.7.2. France.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.7.3. France: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.7.4. France: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.7.5. France: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.8. Conjunctivitis Treatment Market – Germany
10.4.8.1. Germany: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.8.2. Germany.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.8.3. Germany: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.8.4. Germany: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.8.5. Germany: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.9. Conjunctivitis Treatment Market – Italy
10.4.9.1. Italy: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.9.2. Italy.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.9.3. Italy: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.9.4. Italy: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.9.5. Italy: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.10. Conjunctivitis Treatment Market – Spain
10.4.10.1. Spain: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.10.2. Spain.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.10.3. Spain: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.10.4. Spain: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.10.5. Spain: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.11. Conjunctivitis Treatment Market – Netherlands
10.4.11.1. Netherlands: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.11.2. Netherlands.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.11.3. Netherlands: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.11.4. Netherlands: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.11.5. Netherlands: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.4.12. Conjunctivitis Treatment Market – Russia
10.4.12.1. Russia: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.4.12.2. Russia.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.4.12.3. Russia: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.4.12.4. Russia: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.12.5. Russia: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5. Conjunctivitis Treatment Market – Asia Pacific
10.5.1. Asia Pacific: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.2. Asia Pacific.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.3. Asia Pacific: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.4. Asia Pacific: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.5. Asia Pacific: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5.6. Conjunctivitis Treatment Market – China
10.5.6.1. China: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.6.2. China.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.6.3. China: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.6.4. China: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.6.5. China: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5.7. Conjunctivitis Treatment Market – India
10.5.7.1. India: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.7.2. India.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.7.3. India: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.7.4. India: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.7.5. India: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5.8. Conjunctivitis Treatment Market – Japan
10.5.8.1. Japan: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.8.2. Japan.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.8.3. Japan: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.8.4. Japan: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.8.5. Japan: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5.9. Conjunctivitis Treatment Market – Malaysia
10.5.9.1. Malaysia: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.9.2. Malaysia.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.9.3. Malaysia: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.9.4. Malaysia: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.9.5. Malaysia: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5.10. Conjunctivitis Treatment Market – Indonesia
10.5.10.1. Indonesia: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.10.2. Indonesia.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.10.3. Indonesia: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.10.4. Indonesia: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.10.5. Indonesia: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.5.11. Conjunctivitis Treatment Market – South Korea
10.5.11.1. South Korea: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.5.11.2. South Korea.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.5.11.3. South Korea: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.5.11.4. South Korea: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.11.5. South Korea: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.6. Conjunctivitis Treatment Market – Middle East & Africa
10.6.1. Middle East & Africa: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.6.2. Middle East & Africa: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.6.3. Middle East & Africa: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.6.4. Middle East & Africa: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.5. Middle East & Africa: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.6.6. Conjunctivitis Treatment Market – Saudi Arabia
10.6.6.1. Saudi Arabia: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.6.6.2. Saudi Arabia.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.6.6.3. Saudi Arabia: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.6.6.4. Saudi Arabia: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.6.5. Saudi Arabia: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.6.7. Conjunctivitis Treatment Market – UAE
10.6.7.1. UAE: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.6.7.2. UAE.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.6.7.3. UAE: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.6.7.4. UAE: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.7.5. UAE: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.6.8. Conjunctivitis Treatment Market – Israel
10.6.8.1. Israel: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.6.8.2. Israel.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.6.8.3. Israel: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.6.8.4. Israel: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.8.5. Israel: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.6.9. Conjunctivitis Treatment Market – South Africa
10.6.9.1. South Africa: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.6.9.2. South Africa.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.6.9.3. South Africa: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.6.9.4. South Africa: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.9.5. South Africa: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.7. Conjunctivitis Treatment Market – Latin America
10.7.1. Latin America: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.7.2. Latin America.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.7.3. Latin America: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.7.4. Latin America: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.5. Latin America: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.7.6. Conjunctivitis Treatment Market – Mexico
10.7.6.1. Mexico: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.7.6.2. Mexico.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.7.6.3. Mexico: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.7.6.4. Mexico: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.6.5. Mexico: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.7.7. Conjunctivitis Treatment Market – Brazil
10.7.7.1. Brazil: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.7.7.2. Brazil.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.7.7.3. Brazil: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.7.7.4. Brazil: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.7.5. Brazil: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
10.7.8. Conjunctivitis Treatment Market – Argentina
10.7.8.1. Argentina: Conjunctivitis Treatment Market, by Drug Class, 2019-2032 (USD Billion)
10.7.8.2. Argentina.: Conjunctivitis Treatment Market, by Formulation Type, 2019-2032 (USD Billion)
10.7.8.3. Argentina: Conjunctivitis Treatment Market, by Disease Type, 2019-2032 (USD Billion)
10.7.8.4. Argentina: Conjunctivitis Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.8.5. Argentina: Conjunctivitis Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
11. Competitive Landscape
11.1. Expansion and Acquisition Analysis
11.1.1. Expansion
11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
12.1. Abbvie Inc (U.S.)
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Recent Development
12.2. AFT Pharmaceuticals (New Zealand)
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Benchmarking
12.2.4. Recent Development
12.3. Alembic Pharmaceuticals (India)
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Benchmarking
12.3.4. Recent Development
12.4. Bausch Health Companies Inc. (Canada)
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Benchmarking
12.4.4. Recent Development
12.5. Harrow (U.S.)
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Benchmarking
12.5.4. Recent Development
12.6. NicOx SA (France)
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Benchmarking
12.6.4. Recent Development
12.7. Novartis (Switzerland)
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Benchmarking
12.7.4. Recent Development
12.8. Pfizer Inc. (U.S.)
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Benchmarking
12.8.4. Recent Development
12.9. Spectra Vision Care (India)
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Benchmarking
12.9.4. Recent Development
12.10. Sun Pharmaceutical Industries Limited (India)
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Benchmarking
12.10.4. Recent Development
12.11. Teva Pharmaceutical Industries (Israel)
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Benchmarking
12.11.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us